Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Elizabeth Blair

TitleProfessor
InstitutionUniversity of Chicago
DepartmentSurgery-Ohns
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Elizabeth Blair, MD, is a highly regarded surgeon who specializes in head and neck surgery. Dr. Blair is an expert in the diagnosis and treatment of head and neck cancer, thyroid and parathyroid disease, salivary gland tumors and skull base tumors, as well as malignant melanoma and other skin cancers. She has a special interest in treating patients with voice and laryngeal disorders ranging from hoarseness to vocal cord paralysis.

    Dr. Blair's research interests include management of laryngeal and voice disorders, functional outcomes of patients treated for head and neck cancer and development of organ preservation therapies for head and neck malignancies. She also has an interest in early diagnosis and prevention of head and neck cancer.


    Collapse Biography 
    Collapse education and training
    University of Chicago6/2004Clinical Research Training Program
    University of Texas M.D. Anderson Cancer Center, Houston, TX06/1994Fellow, Advanced Head and Neck Surgical Oncology
    University of Pittsburgh, Pittsburgh, PA06/1993Residency, Otolaryngology-Head and Neck Surgery
    Creighton University Affiliated Hospitals, Omaha, NE08/1989Internship/Residency, General Surgery
    Creighton University School of Medicine, Omaha, NEMD05/1988Doctor of Medicine
    Creighton University, Omaha, NEBS, Cum Laude05/1984Chemistry
    Collapse awards and honors
    2012 - 2019Top Doctors, Otolaryngology, Chicago Magazine
    2012 - 2019America’s Top Doctor for Cancer, Castle and Connolly
    2017 - 2019Exceptional Women in Medicine, Top Doctor, Castle and Connolly
    2015Making a Difference Award, Distinguished Hospital Service, University of Chicago Medicine Hospitals
    2013Distinguished Service Honor Award, American Academy of Otolaryngology-Head and Neck Surgery Foundation
    2009Alpha Omega Alpha, Alumni Award, Creighton University School of Medicine
    2004Best Poster Presentation, AAOHNS Annual Meeting
    1998Best Paper, Young Surgical Educators , Society of University Otolaryngologists
    1998Honor Award, American Academy of Otolaryngology-Head and Neck Surgery Foundation
    1998Meritorious Service Medal, US Army
    1997Army Commendation Medal, US Army
    1995 - 1996Army Achievement Medal, US Army

    Collapse ORNG Applications 
    Collapse Featured Presentations
    Collapse Twitter

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Silva AK, Portugal L, Blair EA. In Reference to The Medial Sural Artery Perforator Flap: A Better Option in Complex Head and Neck Reconstruction? Laryngoscope. 2020 Aug; 130(8):E456. PMID: 32343425.
      View in: PubMed
    2. Foster CC, Seiwert TY, MacCracken E, Blair EA, Agrawal N, Melotek JM, Portugal L, Brisson RJ, Gooi Z, Spiotto MT, Vokes EE, Haraf DJ. Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes. Int J Radiat Oncol Biol Phys. 2020 Jul 15; 107(4):662-671. PMID: 32311416.
      View in: PubMed
    3. Cipriani NA, Lusardi JJ, McElherne J, Pearson AT, Olivas AD, Fitzpatrick C, Lingen MW, Blair EA. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. Am J Surg Pathol. 2019 07; 43(7):885-897. PMID: 31021855.
      View in: PubMed
    4. Seiwert TY, Foster CC, Blair EA, Karrison TG, Agrawal N, Melotek JM, Portugal L, Brisson RJ, Dekker A, Kochanny S, Gooi Z, Lingen MW, Villaflor VM, Ginat DT, Haraf DJ, Vokes EE. OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Ann Oncol. 2019 02 01; 30(2):297-302. PMID: 30481287.
      View in: PubMed
    5. McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, Murphy PM. Plerixafor for the Treatment of WHIM Syndrome. N Engl J Med. 2019 01 10; 380(2):163-170. PMID: 30625055.
      View in: PubMed
    6. McMullen PD, Bridge JA, Blair EA, Yang CW, Collins J, Cipriani NA. Aneurysmal Bone Cyst of the Maxillary Sinus with USP6 Rearrangement: Case Report of a Rare Entity and Review of the Literature. Head Neck Pathol. 2019 Sep; 13(3):281-285. PMID: 30076509.
      View in: PubMed
    7. Foster CC, Melotek JM, Brisson RJ, Seiwert TY, Cohen EEW, Stenson KM, Blair EA, Portugal L, Gooi Z, Agrawal N, Vokes EE, Haraf DJ. Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. Oral Oncol. 2018 05; 80:16-22. PMID: 29706184.
      View in: PubMed
    8. Yesensky JA, Hasina R, Wroblewski KE, Bellairs J, Gooi Z, Saloura V, Cipriani NA, Vokes EE, Portugal LG, Seiwert TY, Blair ED, Agrawal N. Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population. Head Neck. 2018 04; 40(4):784-792. PMID: 29356169.
      View in: PubMed
    9. Ginat DT, Blair E. Nasal cavity tumefactive fibroinflammatory lesion mimicking recurrent mucoepidermoid carcinoma. Ear Nose Throat J. 2017 Aug; 96(8):290-293. PMID: 28846782.
      View in: PubMed
    10. Yesensky J, Agrawal N, Bayan S, Blair E, Portugal L, Chan J, Goldenberg D, Gooi Z. AHNS Series - Do you know your guidelines? Principles of treatment for glottic cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 09; 39(9):1729-1732. PMID: 28653453.
      View in: PubMed
    11. Cipriani NA, Blair EA, Finkle J, Kraninger JL, Straus CM, Villaflor VM, Ginat DT. Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib. Int J Surg Pathol. 2017 Oct; 25(7):613-618. PMID: 28497708.
      View in: PubMed
    12. Gooi Z, Richmon J, Agrawal N, Blair E, Portugal L, Vokes E, Seiwert T, de Souza J, Saloura V, Haraf D, Goldenberg D, Chan J. AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 02; 39(2):201-205. PMID: 27898198.
      View in: PubMed
    13. Wali E, Pinto JM, Cappaert M, Lambrix M, Blood AD, Blair EA, Small SD. Teaching professionalism in graduate medical education: What is the role of simulation? Surgery. 2016 09; 160(3):552-64. PMID: 27206333.
      View in: PubMed
    14. Seiwert TY, Melotek JM, Blair EA, Stenson KM, Salama JK, Witt ME, Brisson RJ, Chawla A, Dekker A, Lingen MW, Kocherginsky M, Villaflor VM, Cohen EE, Haraf DJ, Vokes EE. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):21-9. PMID: 27511844.
      View in: PubMed
    15. Villaflor VM, Melotek JM, Karrison TG, Brisson RJ, Blair EA, Portugal L, De Souza JA, Ginat DT, Stenson KM, Langerman A, Kocherginsky M, Spiotto MT, Hannigan N, Seiwert TY, Cohen EE, Vokes EE, Haraf DJ. Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Ann Oncol. 2016 05; 27(5):908-13. PMID: 26884588.
      View in: PubMed
    16. William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16. PMID: 26540028.
      View in: PubMed
    17. Ginat DT, Johnson DN, de Souza J, Blair E. Concurrent fungus ball and squamous cell carcinoma of the maxillary sinus. Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Apr; 133(2):153-4. PMID: 26774379.
      View in: PubMed
    18. Ginat DT, Blair EA. Laryngeal Swelling. JAMA Otolaryngol Head Neck Surg. 2015 Jul; 141(7):667-8. PMID: 26042539.
      View in: PubMed
    19. Ginat DT, Schulte J, Blair EA. A painful lesion of the mandible. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Sep; 132(4):237-8. PMID: 25980314.
      View in: PubMed
    20. Das LC, Karrison TG, Witt ME, Muller C, Stenson K, Blair EA, Cohen EEW, Seiwert TY, Haraf DJ, Vokes EE. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades. Ann Oncol. 2015 Jan; 26(1):198-205. PMID: 25361984.
      View in: PubMed
    21. Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P, Cho J, Lawrence MS, Getz G, Brägelmann J, DeBoer R, Weichselbaum RR, Langerman A, Portugal L, Blair E, Stenson K, Lingen MW, Cohen EE, Vokes EE, White KP, Hammerman PS. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015 Feb 01; 21(3):632-41. PMID: 25056374.
      View in: PubMed
    22. Wong SJ, Campbell B, Massey B, Lynch DP, Cohen EEW, Blair E, Selle R, Shklovskaya J, Jovanovic BD, Skripkauskas S, Dew A, Kulesza P, Parimi V, Bergan RC, Szabo E. A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol. 2013 Sep; 49(9):970-976. PMID: 23845699.
      View in: PubMed
    23. Rudra S, Spiotto MT, Witt ME, Blair EA, Stenson K, Haraf DJ. Lymph node density--prognostic value in head and neck cancer. Head Neck. 2014 Feb; 36(2):266-72. PMID: 23765406.
      View in: PubMed
    24. Seiwert TY, Darga T, Haraf D, Blair EA, Stenson K, Cohen EE, Salama JK, Villaflor V, Witt ME, Lingen MW, Weichselbaum RR, Vokes EE. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Ann Oncol. 2013 Mar; 24(3):769-76. PMID: 23104721.
      View in: PubMed
    25. Golden DW, Rudra S, Witt ME, Nwizu T, Cohen EE, Blair E, Stenson KM, Vokes EE, Haraf DJ. Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma. Oral Oncol. 2013 Mar; 49(3):277-82. PMID: 23102863.
      View in: PubMed
    26. Mouw KW, Solanki AA, Stenson KM, Witt ME, Blair EA, Cohen EEW, Vokes EE, List M, Haraf DJ, Salama JK. Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy. Oral Oncol. 2012 Oct; 48(10):1025-1030. PMID: 22621836.
      View in: PubMed
    27. Perez CA, Song H, Raez LE, Agulnik M, Grushko TA, Dekker A, Stenson K, Blair EA, Olopade OI, Seiwert TY, Vokes EE, Cohen EE. Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2012 Sep; 48(9):887-92. PMID: 22513208.
      View in: PubMed
    28. de Souza JA, Davis DW, Zhang Y, Khattri A, Seiwert TY, Aktolga S, Wong SJ, Kozloff MF, Nattam S, Lingen MW, Kunnavakkam R, Stenson KM, Blair EA, Bozeman J, Dancey JE, Vokes EE, Cohen EE. A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Apr 15; 18(8):2336-43. PMID: 22371453.
      View in: PubMed
    29. Andrews JD, Nocon CC, Small SM, Pinto JM, Blair EA. Emergency airway management: training and experience of chief residents in otolaryngology and anesthesiology. Head Neck. 2012 Dec; 34(12):1720-6. PMID: 22287361.
      View in: PubMed
    30. Stenson KM, Maccracken E, Kunnavakkam R, W Cohen EE, Portugal LD, Villaflor V, Seiwert T, Blair E, Haraf DJ, Salama JK, Vokes EE. Chemoradiation for patients with large-volume laryngeal cancers. Head Neck. 2012 Aug; 34(8):1162-7. PMID: 22052816.
      View in: PubMed
    31. Pederson AW, Salama JK, Witt ME, Stenson KM, Blair EA, Vokes EE, Haraf DJ. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. Am J Clin Oncol. 2011 Aug; 34(4):356-61. PMID: 21633289.
      View in: PubMed
    32. Pederson AW, Salama JK, Haraf DJ, Witt ME, Stenson KM, Portugal L, Seiwert T, Villaflor VM, Cohen EE, Vokes EE, Blair EA. Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies. Head Neck Oncol. 2011 Jul 26; 3:31. PMID: 21791072.
      View in: PubMed
    33. Choe KS, Haraf DJ, Solanki A, Cohen EE, Seiwert TY, Stenson KM, Blair EA, Portugal L, Villaflor VM, Witt ME, Vokes EE, Salama JK. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Cancer. 2011 Oct 15; 117(20):4671-8. PMID: 21671479.
      View in: PubMed
    34. Villaflor VM, Haraf D, Salama JK, Kocherginsky M, Langerman A, Gomez-Abuin G, Beniwal P, Blair EA, Stenson KM, Portugal L, Seiwert T, Williams RD, Dekker AJ, Witt ME, Vokes EE, Cohen EEW. Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Ann Oncol. 2011 Nov; 22(11):2501-2507. PMID: 21385883.
      View in: PubMed
    35. Langerman A, Patel RM, Cohen EE, Blair EA, Stenson KM. Airway management before chemoradiation for advanced head and neck cancer. Head Neck. 2012 Feb; 34(2):254-9. PMID: 21384461.
      View in: PubMed
    36. Salama JK, Haraf DJ, Stenson KM, Blair EA, Witt ME, Williams R, Kunnavakkam R, Cohen EE, Seiwert T, Vokes EE. A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers. Ann Oncol. 2011 Oct; 22(10):2304-9. PMID: 21330337.
      View in: PubMed
    37. Mouw KW, Haraf DJ, Stenson KM, Cohen EE, Xi X, Witt ME, List M, Blair EA, Vokes EE, Salama JK. Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1226-34. PMID: 21173372.
      View in: PubMed
    38. Pederson AW, Haraf DJ, Witt ME, Stenson KM, Vokes EE, Blair EA, Salama JK. Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. Head Neck. 2010 Nov; 32(11):1519-27. PMID: 20187015.
      View in: PubMed
    39. Choe KS, Salama JK, Stenson KM, Blair EA, Witt ME, Cohen EE, Haraf DJ, Vokes EE. Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer. Radiother Oncol. 2010 Nov; 97(2):318-21. PMID: 20934766.
      View in: PubMed
    40. Cohen EE, Haraf DJ, Kunnavakkam R, Stenson KM, Blair EA, Brockstein B, Lester EP, Salama JK, Dekker A, Williams R, Witt ME, Grushko TA, Dignam JJ, Lingen MW, Olopade OI, Vokes EE. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2010 Jul 10; 28(20):3336-43. PMID: 20498391.
      View in: PubMed
    41. Pederson AW, Haraf DJ, Blair EA, Stenson KM, Witt ME, Vokes EE, Salama JK. Chemoreirradiation for recurrent salivary gland malignancies. Radiother Oncol. 2010 Jun; 95(3):308-11. PMID: 20385414.
      View in: PubMed
    42. Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, Salama J, Vokes EE. Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope. 2010 Jan; 120(1):93-9. PMID: 19856305.
      View in: PubMed
    43. Cipriani NA, Blair E, Taxy JB. WHIM syndrome and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jan; 109(1):105-8. PMID: 19926501.
      View in: PubMed
    44. Gurevich-Uvena J, Parker JM, Fitzpatrick TM, Makashay MJ, Perello MM, Blair EA, Solomon NP. Medical comorbidities for paradoxical vocal fold motion (vocal cord dysfunction) in the military population. J Voice. 2010 Nov; 24(6):728-31. PMID: 19892521.
      View in: PubMed
    45. Langerman A, Plein C, Vokes EE, Salama JK, Haraf DJ, Blair EA, Stenson KM. Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2009 Nov; 135(11):1133-6. PMID: 19917927.
      View in: PubMed
    46. Bamba R, Sweiss NJ, Langerman AJ, Taxy JB, Blair EA. The minor salivary gland biopsy as a diagnostic tool for Sjogren syndrome. Laryngoscope. 2009 Oct; 119(10):1922-6. PMID: 19650134.
      View in: PubMed
    47. Cohen EE, Baru J, Huo D, Haraf DJ, Crowley M, Witt ME, Blair EA, Weichselbaum RR, Rosen F, Vokes EE, Stenson K. Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head Neck. 2009 Aug; 31(8):1013-21. PMID: 19340870.
      View in: PubMed
    48. Cohen EE, Davis DW, Karrison TG, Seiwert TY, Wong SJ, Nattam S, Kozloff MF, Clark JI, Yan DH, Liu W, Pierce C, Dancey JE, Stenson K, Blair E, Dekker A, Vokes EE. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. Lancet Oncol. 2009 Mar; 10(3):247-57. PMID: 19201650.
      View in: PubMed
    49. Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008 Oct; 134(10):1060-5. PMID: 18936351.
      View in: PubMed
    50. Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Mult Scler. 2008 Jul; 14(6):809-14. PMID: 18573828.
      View in: PubMed
    51. Villaflor VM, Cohen EE, Haraf D, Stenson K, Blair E, Salama J, Portugal L, Williams R, Thomas A, Gomez-Abuin G, Vokes EE. Phase II trial pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated head and neck cancer patients. J Clin Oncol. 2008 May 20; 26(15_suppl):6030. PMID: 27950566.
      View in: PubMed
    52. Vokes EE, Seiwert TY, Blair E, Cohen EE, Salama J, Villaflor VM, Witt M, Kovacevic M, Stenson K, Haraf D. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer (HNC). J Clin Oncol. 2008 May 20; 26(15_suppl):6067. PMID: 27947830.
      View in: PubMed
    53. Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EE. A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer. Cancer Invest. 2007 Sep; 25(6):435-44. PMID: 17882655.
      View in: PubMed
    54. Langerman AJ, Blair EA, Sweiss NJ, Taxy JB. Utility of lip biopsy in the diagnosis and treatment of Sjogren's syndrome. Laryngoscope. 2007 Jun; 117(6):1004-8. PMID: 17417107.
      View in: PubMed
    55. Sigari F, Blair E, Redleaf M. Headache with unilateral pulsatile tinnitus in women can signal dural sinus thrombosis. Ann Otol Rhinol Laryngol. 2006 Sep; 115(9):686-9. PMID: 17044540.
      View in: PubMed
    56. Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, Vokes EE. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope. 2006 Jan; 116(1):33-6. PMID: 16481805.
      View in: PubMed
    57. Fitzpatrick TM, Blair EA. Upper airway complications of smoking. Clin Chest Med. 2000 Mar; 21(1):147-57, x. PMID: 10763096.
      View in: PubMed
    58. Mann EA, Blair EA, Levy AJ, Chang A. Effect of topical antibiotic therapy on recovery after tonsillectomy in adults. Otolaryngol Head Neck Surg. 1999 Sep; 121(3):277-82. PMID: 10471871.
      View in: PubMed
    59. Blair EA, Goepfert H . Thyroid Nodule, Current Therapy Otolaryngology/Head and Neck Surgery. 1997.
    60. Blair EA, Johnson JT, Wagner RL, Carrau RL, Bizakis JG. Cost analysis of antibiotic prophylaxis in clean head and neck surgery. Arch Otolaryngol Head Neck Surg. 1995 Mar; 121(3):269-71. PMID: 7873141.
      View in: PubMed
    61. Blair EA, Barnes G. . Berger DH, Feig BW, Fuhrman GM eds. M.D. Anderson Surgical Oncology Handbook. 1994. Carcinoma of the Thyroid and Parathyroid Glands. 1995.
    62. Blair EA, Teeple E, Sutherland RM, Shih T, Chen D. Effect of neuromuscular blockade on facial nerve monitoring. Am J Otol. 1994 Mar; 15(2):161-7. PMID: 8172295.
      View in: PubMed
    63. Blair EA, Callender DL. Head and neck cancer. The problem. Clin Plast Surg. 1994 Jan; 21(1):1-7. PMID: 8112003.
      View in: PubMed
    64. Sterpetti AV, Blair EA, Schultz RD, Feldhaus RJ, Cisternino S, Chasan P. Sealed rupture of abdominal aortic aneurysms. J Vasc Surg. 1990 Mar; 11(3):430-5. PMID: 2138232.
      View in: PubMed
    65. Sterpetti AV, Feldhaus RJ, Schultz RD, Blair EA. Identification of abdominal aortic aneurysm patients with different clinical features and clinical outcomes. Am J Surg. 1988 Dec; 156(6):466-9. PMID: 3202258.
      View in: PubMed
    66. Sterpetti AV, Hunter WJ, Schultz RD, Sugimoto JT, Blair EA, Hacker K, Chasan P, Valentine J. Seeding with endothelial cells derived from the microvessels of the omentum and from the jugular vein: a comparative study. J Vasc Surg. 1988 May; 7(5):677-84. PMID: 3367433.
      View in: PubMed
    Blair's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (299) concept(s)
    _
    Co-Authors Expand Description
    See all (34) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _